Long-term outcome of magnetic resonance spectroscopic image–directed dose escalation for prostate brachytherapy-Reference-Cited by-同舟云学术

Long-term outcome of magnetic resonance spectroscopic image–directed dose escalation for prostate brachytherapy

Published:2016-05 Issue:3 Volume:15 Page:266-273
ISSN:1538-4721
Container-title:Brachytherapy
language:en
Short-container-title:Brachytherapy

Author:

King Martin T.,Nasser Nicola J.,Mathur Nitin,Cohen Gil'ad N.,Kollmeier Marisa A.,Yuen Jasper,Vargas Hebert A.,Pei Xin,Yamada Yoshiya,Zakian Kristen L.,Zaider Marco,Zelefsky Michael J.

Funder

National Institutes of Health

Jan Calloway

Wayne Calloway

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference35 articles.

1. Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer;Kuban;Int J Radiat Oncol Biol Phys,2008

2. Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/American College of Radiology 95-09;Zietman;J Clin Oncol,2010

3. Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes;Zelefsky;Int J Radiat Oncol Biol Phys,2008

4. A dose-response study for I-125 prostate implants;Stock;Int J Radiat Oncol Biol Phys,1998

5. Predicting biochemical tumor control after brachytherapy for clinically localized prostate cancer: the Memorial Sloan-Kettering Cancer Center experience;Zelefsky;Brachytherapy,2012

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brachytherapy based microboosting to the dominant intraprostatic lesion in prostate cancer: A systematic review on treatment outcomes and toxicities;Brachytherapy;2024-09

2. Focal Boost in Prostate Cancer Radiotherapy: A Review of Planning Studies and Clinical Trials;Cancers;2023-10-08

3. Brachytherapy focal dose escalation using ultrasound based tissue characterization by patients with non-metastatic prostate cancer: Five-year results from single-center phase 2 trial;Brachytherapy;2022-07

4. Automatic localization of the prostatic urethra for image guided radiation therapy;Technical Innovations & Patient Support in Radiation Oncology;2021-09

5. Tumor-targeted dose escalation for localized prostate cancer using MR-guided HDR brachytherapy (HDR) or integrated VMAT (IB-VMAT) boost: Dosimetry, toxicity and health related quality of life;Radiotherapy and Oncology;2020-08